NCT07219485 A Study of Pitolisant in Participants With Prader-Willi Syndrome Status ENROLLING_BY_INVITATION Phase PHASE3
NCT05953389 Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05458128 A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia Status COMPLETED Phase PHASE3
NCT05223166 A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA Status COMPLETED Phase PHASE3
NCT04596267 Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers Status TERMINATED Phase PHASE1
NCT04026750 Insulin Tolerance Test Study in Patients With Type 1 Diabetes Status TERMINATED Phase PHASE1
NCT03433131 Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy Status NO_LONGER_AVAILABLE Phase N/A
NCT03152123 Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users Status COMPLETED Phase PHASE1
NCT02929342 Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02611687 Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period Status COMPLETED Phase PHASE3
NCT01800045 Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP) Status COMPLETED Phase PHASE3